High-performance liquid chromatography (HPLC) coupled to a diode-array detector (DAD) and electrospray ionization mass spectrometry (MS) was applied for the separation and identification of phenolic compounds in the n-hexane, ethyl acetate and methanol crude extract of Barbacenia blanchetii. The MS, MSn and UV data together with chemosystematic evidence allowed the structural characterization of five compounds: tricin, chrysoeriol, epi-gallocatechin, kaempferol 3-O-glucoside and caffeoylquinic acid. At the same time, these extracts were evaluated against butyrylcholinesterase using Ellman's method. All extracts inhibited BuChE in a concentration-dependent form; however, the methanol extract showed a better effect that the other extracts. These compounds have been identified previously in the Velloziaceae family, but for the first time as constituents of B. blanchetii.
The Velloziaceae family is an important source of phenolic compounds including glycosylated and non-glycosylated flavonoids, uncommon in nature [1] . The genus Barbacenia contains approximately 110 species distributed mainly in the Brazilian semiarid region [2] . Species of this genus produce flavonoid derivatives, but can be distinguished from other genera in the family due to the presence of isorhamnetin and the occasional presence of quercetin 3-methyl ether. The flavonol nonglycosylated kaempferol was found in several species of Barbacenia, whereas the flavone tricin only in B. riedeliana [3] . Another chemosystematic study revealed complex mixtures of flavonol mono-O-and di-O-glycosides within the leaves of Barbacenia species [4] .
Butyrylcholinesterase (BuChE, EC 3.1.1.8) is a non-neuronal cholinesterase widely distributed in different tissues of the human body, such as liver, lung and heart. Alzheimer's disease (Ad) is associated with decreased rates of acetylcholine in the synaptic process, decreasing cortical cholinergic neurotransmission. The structural diversity of known BuChE inhibitors and the ability to explore different modes of action of this enzyme have stimulated the phytochemical study of various plants, which can provide new models of action for these substances [5, 6] .
Reverse phase high-performance liquid chromatography with diodearray and an electrospray ionization mass spectrometer detector (RP-HPLC-DAD-MS n ) was used for the identification of the phenolic compounds in the crude extracts of B. blanchetii Goerth & Henrard. The chromatograms in positive ion mode are shown in Figure 1 . Table 1 gives the UV and MS results for the chromatographic peaks in the ethyl acetate and methanol extracts, along with the proposal for their phenolic chemical structure. The nhexane extract was not positive for phenolic compounds. Several molecular ions peaks present in the chromatograms showed the formation of complexes of the [2M + Na] + type due to the formation of complexes between sodium and oxygen atoms of the hydroxyl groups, which can also be stabilized by intermolecular hydrogen bonds [7, 8] . The MS of compound 1 showed a protonated molecular ion peak at m/z 331 [M+H] + and a prominent fragment ion at m/z 315 corresponding to loss of a methyl group.
The UV spectrum with λ max at 267 and 347 nm was consistent with a flavone skeleton containing a trihydroxylated ring-B [9] . These data allow the identification of compound 1 as tricin; this compound was previously isolated from the leaves of Vellozia coronata, V. epidendroides, V. glabra, and V. lilacina [1] . Peaks 3 and 4 were attributed to epi-gallocatechin and chrysoeriol, respectively, due to their UV and mass spectra when compared with literature data [10] [11] [12] . Three phenolic compounds could be identified in the methanol extract. The compound forming peak 6 presented an UV spectrum characteristic of caffeoyl derivatives [13] , and a MS with a protonated molecular ion at m/z 355 [14] . The data above, together with the fact that Vellozia species produce phenolic acids [15] , allowed us to identify this compound as caffeoylquinic acid. Compound 7 showed an UV spectrum matching that of flavonol-3-O-substitued compounds [16] . The MS of 7 showed a protonated molecular ion at m/z 449 and fragmentations at m/z 431 [(M+H) -18] + , and 413 [(M+H) -18 -18] + produced by loss of one and two molecules of water, respectively [17] . Compound 8 showed the same chromatographic retention time and spectral data as compound 1, and was also characterized as tricin. Compounds 2 and 5 are described here as unknown. However, 2 showed spectral data characteristic of polymethoxylated flavonoid compounds found previously in the Velloziaceae family, as for example pleurostimim 7-methyl ether isolated from Vellozia sp [18] and 8-C-methyl-5,3',4',trihydroxy-3-6-7-trimetoxy flavone isolated from V. lilacina, V. aff. epidendroides and V. nanuzae [18, 19] . Compound 5 produced a molecular ion at m/z 689 and can be rationalized as a diglucosylated derivative of compound 2 due to the presence of fragments formed by the loss of two hexose units [(M+H) -162 -162] + and the formation of a protonated aglycone at m/z 365. Polymethoxylated flavonoids linked with a sugar unit are uncommon in nature [20] and these substances are being isolated in our laboratory and will be reported in the near future.
In Figure 2 the inhibitory activity is shown of the n-hexane, ethyl acetate and methanolic extracts of B. blanchetii evaluated in vitro against butyrylcholinesterase. All extracts inhibited BuChE in a dose-dependent manner. The IC 50 values for the n-hexane extract were 0.09 mg/mL [0.07-0.11 mg/mL] and 0.11 mg/mL [0.09 to 0.14 mg/mL] for 30 and 60 minutes, respectively, and maximal inhibition was 62.3%, with R2 equal to 0.98. The IC 50 values for the ethyl acetate extract were 0.49 mg/mL [0.36-0.66 mg/mL] and 0.57 mg/mL [0.42-0.77 mg/mL] for 30 to 60 minutes, and maximal inhibition was 67.9% (R2 = 0.97 for both reading times). The methanol extract gave IC 50 values of 0.43 mg/mL [0.22-0.81 mg/mL] and 0.43 mg/mL [0.22-0.84 mg/mL] for 30 and 60 minutes, respectively; maximal inhibition was 70.9%, and R2 for both reading times was equivalent to 0.91.
Flavonoids have shown cholinesterase activity; however, the pattern of substitution in the nucleus of the flavonoid is of fundamental importance. Structure-activity relationships revealed that sugar bonded in the flavonoid ring acts positively in inhibiting cholinesterase [21] . Thus, the flavonoid glycoside in the methanol extract may explain in part its inhibition of butyrylcholinesterase. A study conducted with different subclasses of flavonoids (e.g. flavonones, flavones, flavonols and isoflavones) revealed their potential in the in vitro inhibition of AChE activity. The results suggest that natural compounds may be potential candidates for the development of new drugs against Alzheimer's disease [22] . Among the flavonoids evaluated, galangin isolated from the rhizomes of Alpinia officinarum Hance. showed greater inhibitory effect, with inhibition of over 55% and an IC 50 of 120 mM. In another study, it was also demonstrated that various flavonoids, including galangin, modulate the activity of human BuChE at non-cytotoxic concentrations, bringing good prospect for the treatment of the symptoms of neurodegenerative diseases such as Alzheimer's disease [21] . The structural characteristics of these compounds showed potential for the inhibition of BuChE due to the number and position of hydroxyl groups, which can form multiple hydrogen bonds at the active site of the enzyme. However, the presence of glycoside units represents a steric hindrance for the accommodation of the flavonoid on the active site of BuChE, resulting in lower potency of inhibition [21] .
The extracts of B. blanchetii inhibited BuChE in a dose-dependent manner. The HPLC-DAD-MS/MS investigation showed the presence of flavonoids in the extracts tested. The flavonoids identified in the ethyl acetate extract were aglycones, whereas the methanolic extract contains a phenolic acid and kaempferol-3-Oglucoside. This latter compound may be responsible for the different in vitro inhibition activity against butyrylcholinesterase between the extracts. Extracts preparation Aerial parts of B. blanchetii (1 Kg) were dried, powdered and extracted with n-hexane, ethyl acetate and methanol successively at room temperature. Afterwards, the solvents were removed under vacuum and the respective extracts were obtained in yields of 63, 78 and 82 g, respectively
Evaluation of BuChE inhibition:
The activity of butyrylcholinesterase (BuChE) was evaluated according to Ellman's method [23] , with minor micro-scale adaptations. The protocol employed maintained constant substrate concentration, while the concentration of the sample was variable. We evaluated the concentration that inhibits 50% of the activity of butyrylcholinesterase (IC 50 ) and maximal inhibition of the enzyme (Emax). The absorbance was read at times 0, 30 and 60 min after addition of substrate, and time zero was considered as the background of the reaction. All assays were performed in triplicate in 2 independent experiments. Trials with neostigmine 1 µg/mL (final concentration in the plate) were performed on all plates in triplicate and positive control concentration-inhibition curves for neostigmine (1 mM to 0.1 mM) were also performed, following the same protocol used for the extracts.
Statistical analysis:
The IC 50 and Emax were determined by means of non-linear regression. Data were expressed as means and standard deviation for the Emax or means and confidence interval for the IC 50 . The graphs were expressed as % activity versus log of concentration. The Emax presented equals 100% -%activity. The differences in inhibition between 30 and 60 min were analyzed by Student's t-test. A significance level of 5% was set for all analyses. The program GraphPad PrismTM (version 5.0) was used for the analysis.
HPLC-DAD-MS/MS analysis:
Analyses were performed on an Esquire 3000 Plus chromatograph equipped with a diode array detector and mass detector in series (Brucker Daltonics). A Purospher® STAR RP-18e (250 mm X 4.6 mm i.d., 5 μm) (Merck) with suitable guard column was employed for the separation. The mobile phase was composed of solvent (A) H 2 O/H 3 PO 4 0.1% and solvent (B) MeOH. The solvent gradient was composed of A (75-0%) and B (25-100%) for 20 min, then 100% B for 4 min, then again at the initial conditions (75% A and 25% B) for 10 min. A flow rate of 1.0 mL/min was used in a 30°C oven, and 20 μL of each sample was injected. The procedure was repeated 3 times for each sample. Samples and mobile phases were filtered through a 0.22 μm Millipore filter prior to HPLC injection. Spectral data for all peaks were recorded in the range of 200-400 nm during the entire run. The electrospray ionization conditions were adjusted at 300°C and 4000 V for capillary temperature and voltage, respectively. The nebulizer pressure was 12 psi and the nitrogen flow rate was 5 L/min. All mass spectrometric data were recorded in positive ion mode.
